Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

ScinnoHub Pharmaceutical discovers plasmin inhibitors

July 27, 2022

Biallelic variants in RASGRP2 gene tied to bleeding diathesis

July 21, 2022

Fgg-impaired zebrafish present dysfibrinogenemia

July 19, 2022

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

July 18, 2022

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

PCYOX1 identified as new target for antithrombotic therapy

July 18, 2022

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

CM-352 reduces MMP10-driven fibrinolysis in rivaroxaban-associated ICH

July 15, 2022

FVIII-QQ gene transfer therapy shows advantage for treating hemophilia A

July 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...